You are on page 1of 18

HEMP SEED TO SALE

SEED SALE

SEED RESEARCH & HEALTH CANADA MANUFACTURE TESTING & STORAGE & MARKET SALE
DEVELOPMENT LICENSE ANALYSIS DISTRIBUTION CONSUMER
CENTER PRODUCTS
MANUFACTURING DIVISION






HEMP CENTRE OF EXCELLENCE , PENTICTON BC

BUILDING HISTORY AND VISION


● ●



6

PRIVATE AND CONFIDENTIAL


CONSUMER PRODUCTS RETAIL DISTRIBUTION
NATURAL ADVANCEMENT

● INDUSTRY OPPORTUNITY

*Euromonitor, 2016
EARTH’S MENU
Our line of all natural superfoods!




INDUSTRY OPPORTUNITY

*Technavio, Euromonitor 2016


NATURAL PET SCIENCE
Our line of innovative pet food and pet supplements



INDUSTRY OPPORTUNITY

*Euromonitor, 2016

PRIVATE AND
CONFIDENTIAL
CHANVREHEMP
is our line of hemp based all natural skin care



INDUSTRY OPPORTUNITY

*Euromonitor, 2016

PRIVATE AND CONFIDENTIAL


MILESTONES

12
MILESTONES
CAPITAL STRUCTURE
Founders 22,605,000

Employees
35.1 MILLION SHARES 2,200,000
Total Outstanding
Cash Shares 38,058,025

Cannalogix S/H’s 3,095,000


X PoA
Haltain SHARES
(Legacy S/H’s) 1,512,684
held by Management and Employees

X Shares FINANCIALS
Locked up
Cash 1,650,000

Retained Cash from New 850,000


Financing

Penticton FacilityBioscience
In EastWest 7,500,000
MANAGEMENT & BOARD OF DIRECTORS

RODNEY GELINEAU SCOTT REEVES NATHAN LIDDER DOUGLAS HORNE


President Chairman Corporate Development Specialist
Legal Counsel

15
ADVISORY BOARD

HITESH VYAS PRITESH KUMAR STEVE LANGFORD


Technical Director Consumer Products Advisor
President of KYDS

16
17
DISCLAIMER

This presentation (the “Presentation”) has been prepared solely for information purposes in connection with the contemplated issue of shares in EastWest Science (“EWS” or the “Company”)
and is being furnished by EWS to a limited number of parties (the “Recipients”) who have a potential interest in subscribing shares in the Company.
The Presentation is strictly confidential and any disclosure, use, copying and circulation of this Presentation is prohibited without the consent from the Company. The information contained in
this Presentation does not constitute or form part of, and should not be construed as, an offer or invitation to subscribe for or purchase the securities discussed herein in any jurisdiction. Neither
this Presentation nor any part of it shall form the basis of, or be relied upon in connection with any offer, or act as an inducement to enter into any contract or commitment whatsoever. No
representation or warranty is given, express or implied, as to the accuracy of the information contained in the Presentation.
This Presentation contains certain forward-looking statements relating to the business, financial performance and results of the Company and/or the industry in which it operates Forward which
it operates. Forward-looking statements concern future circumstances that are not historical facts. The forward-looking looking statements, contained in this Presentation, including
assumptions, opinions and views of the Company or cited from third party sources are solely opinions and forecasts which are uncertain and subject to risks. A multitude of factors can cause
actual events to differ significantly from any anticipated development. Neither the Company nor its subsidiary undertakings or any such person’s officers or employees guarantee that the
assumptions underlying such forward-looking statements are free from errors and omissions nor does any of them accept any responsibility for the future accuracy of the opinions expressed in
this Presentation or the actual occurrence of the forecasted developments.
The information contained herein has been prepared to assist the Recipients in making their own evaluation on the Company and does purport to contain all information that they may desire. In
all cases, the Recipients should conduct their own investigation and analysis of the Company, its business, prospects, results of operations and financial condition as well as any other
information the Recipients may deem relevant. The Company makes no representation or warranty, express or implied, as to the accuracy or completeness of this Presentation or of the
information contained herein and neither of such parties (including without limitation their directors, employees, representatives and advisors) shall have any liability for the information contained
in, or any omissions from, this Presentation, nor for any of the written, electronic or oral communications transmitted to the Recipients (including without limitation its directors, employees,
representatives and advisors).
Neither the receipt of this Presentation by any Recipients, nor any information contained herein or supplied herewith or subsequently communicated in written, electronic or oral form to any
person in connection with the contemplated issue of shares in the Company constitutes, or shall be relied upon as constituting, the giving of investment advice by the Company or anyone else to
any such person. Each person should make their own independent assessment of the merits of investing in the Company and should consult their own professional advisors. By receiving this
Presentation, you acknowledge and agree that you will be solely responsible for your own assessment of the market and the market position of the Company and that you will conduct your own
analysis and be solely responsible for forming your own opinion of the potential future performance of the Company’s business.
The Presentation is at the date hereof. Neither the delivery of this Presentation nor any further discussions in relation to the Company or the contemplated issue of shares with any of the
Recipients shall, under any circumstances, create any implication that there has been no change in the affairs of the Company since the date of this Presentation.

PRIVATE AND CONFIDENTIAL